World of DTC Marketing

MAY 26, 2021

AbbVie’s internal documents show that from 2015 to 2018, senior executive bonuses were tied directly to Humira’s net revenue, allowing them to profit from AbbVie’s price increases. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars.

Competition 180

Competition Marketing Government Patients 180

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. For example, AbbVie had obtained more than 100 patents for Humira.

Competition 59

Competition Marketing FDA Physicians 59

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage.

Media 83

Media Healthcare Healthcare Education 83

PM360

MAY 15, 2023

For example, starting in 2015 at Ogilvy, I watched companies that had been using print materials in doctors’ offices begin switching to large electronic tablets in waiting and exams rooms that displayed information for multiple brands. An entire academic ecosystem is focused on physician “nudging.”

Marketing 52

Marketing Electronics Doctors Physicians 52

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 93

Government Recruitment Medicine Competition 93

Impetus Digital

JANUARY 3, 2023

A couple of years ago, I first wrote about how social media’s role in the Pharma and healthcare sectors has been growing exponentially. In recent years, social media has evolved into an essential part of Pharma operations, for better or worse. . Pharma companies have to be careful when considering their involvement.

Media 52

Media Healthcare Healthcare Recruitment 52

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Healthcare Success

MAY 3, 2021

But quite often, the audience is bombarded with retail sales pitches—tons of them—for the likes of AARP, pharma brands, Medicare Advantage, hearing aids, wellness devices, retirement communities, life insurance, cosmetics and many others. Let’s explore how to leverage your message ahead of the competition.

Distribution 90

Distribution Marketing Healthcare Healthcare 90

pharmaphorum

SEPTEMBER 21, 2022

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. The US Court of Appeals for the Federal Circuit (CAFC) has denied the Swiss pharma group’s petition to rehear its decision on the validity of US Patent No. Gilenya made revenues of $2.8

Competition 52

Competition Pharma Sales Marketing 52

World of DTC Marketing

JUNE 13, 2022

If pharma wants to retain people, they may have to develop a solution to lower healthcare insurance premiums. As an employer, providing health insurance to your employees can give your company a competitive edge, as it can enhance your employees’ overall satisfaction and productivity.

Insurance 201

Insurance Healthcare Healthcare Consulting 201

Pharmaceutical Technology

SEPTEMBER 26, 2022

Both Sandoz and Novartis are internationally renowned pharma companies, with a combined 34 production facilities worldwide. Strong competition limits Sandoz's growth. On 30 September 2015, GSK agreed to pay $5.25bn for Novartis's vaccines business, while Novartis purchased GSK's oncology division for $16bn.

Competition 64

Competition Manufacturing Marketing Distribution 64

pharmaphorum

OCTOBER 10, 2022

Teva’s last remaining Copaxone (glatiramer acetate) patent expired in Europe in February 2015 and the Commission said last March it was investigating whether the company acted lawfully in trying to delay the entry of lower-cost generic versions of the drug.

Competition 52

Competition Marketing Medicine Pharma 52

PM360

AUGUST 9, 2022

Then between 2005-2015, there were 110 global blockbuster launches, with a high concentration in specialty care and biologics. Pricing regulations in China, a priority emerging market for most of large pharma, has significantly limited growth potential. During this time, 69 blockbusters will lose patents.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Pharmaceutical Technology

JULY 25, 2022

With decreasing margins on the horizon, pharma manufacturers have long shown an interest in specialty generics, which is only expected to rise in the future. But this also means potentially stiffer competition for chemical entities and small molecules in comparison to biosimilars, states Vasquez.

Manufacturing 119

Manufacturing Marketing FDA Pharmaceutical 119

pharmaphorum

JANUARY 16, 2023

Ageing will only compound the challenge: high income country populations are already old, but between 2015 and 2050, the proportion of the world’s population aged over 60 will nearly double, from 12% to 22%, and, by 2050, 80% of older people will be living in low- and middle-income countries.

FDA 85

FDA Healthcare Healthcare Medicine 85

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.

Manufacturing 52

Manufacturing Physicians Prescription FDA 52

World of DTC Marketing

JUNE 7, 2021

AARP recently found that the average annual cost for one brand name medication used on a chronic basis was $6,604 in 2020, more than $1,500 higher than the average annual cost of therapy in 2015. Senator Amy Klobuchar has proposed the Competition and Antitrust Law Enforcement Reform Act. The post The perfect storm is coming for pharma.

Pharma 187

Pharma Retail Prescription Competition 187

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. They need real time visibility platforms and command centres to guarantee complete oversight of the pharma supply chain.

Pharma 59

Pharma Pharmaceutical Distribution Patients 59

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. They need real time visibility platforms and command centres to guarantee complete oversight of the pharma supply chain.

Pharma 52

Pharma Pharmaceutical Distribution Patients 52